Inhibition of Human Neutrophil Elastase. 4. Design, Synthesis, X-ray Crystallographic Analysis, and Structure−Activity Relationships for a Series of P2-Modified, Orally Active Peptidyl Pentafluoroethyl Ketones

1998 ◽  
Vol 41 (14) ◽  
pp. 2461-2480 ◽  
Author(s):  
Robert J. Cregge ◽  
Sherrie L. Durham ◽  
Robert A. Farr ◽  
Steven L. Gallion ◽  
C. Michelle Hare ◽  
...  
1994 ◽  
Vol 37 (26) ◽  
pp. 4538-4553 ◽  
Author(s):  
Michael R. Angelastro ◽  
Larry E. Baugh ◽  
Philippe Bey ◽  
Joseph P. Burkhart ◽  
Teng-Man Chen ◽  
...  

1997 ◽  
Vol 40 (12) ◽  
pp. 1876-1885 ◽  
Author(s):  
Philip D. Edwards ◽  
Donald W. Andisik ◽  
Craig A. Bryant ◽  
Barbara Ewing ◽  
Bruce Gomes ◽  
...  

2000 ◽  
Vol 43 (26) ◽  
pp. 4927-4929 ◽  
Author(s):  
Kazuyuki Ohmoto ◽  
Tetsuya Yamamoto ◽  
Toshihide Horiuchi ◽  
Hirotoshi Imanishi ◽  
Yoshihiko Odagaki ◽  
...  

2020 ◽  
Vol 21 (7) ◽  
pp. 2560 ◽  
Author(s):  
Majid Ali ◽  
Murat Bozdag ◽  
Umar Farooq ◽  
Andrea Angeli ◽  
Fabrizio Carta ◽  
...  

A drug design strategy of carbonic anhydrase inhibitors (CAIs) belonging to sulfonamides incorporating ureidoethylaminobenzyl tails is presented. A variety of substitution patterns on the ring and the tails, located on para- or meta- positions with respect to the sulfonamide warheads were incorporated in the new compounds. Inhibition of human carbonic anhydrases (hCA) isoforms I, II, IX and XII, involving various pathologies, was assessed with the new compounds. Selective inhibitory profile towards hCA II was observed, the most active compounds being low nM inhibitors (KIs of 2.8–9.2 nM, respectively). Extensive X-ray crystallographic analysis of several sulfonamides in an adduct with hCA I allowed an in-depth understanding of their binding mode and to lay a detailed structure-activity relationship.


2001 ◽  
Vol 11 (2) ◽  
pp. 243-246 ◽  
Author(s):  
Simon J.F Macdonald ◽  
Michael D Dowle ◽  
Lee A Harrison ◽  
Julie E Spooner ◽  
Pritom Shah ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document